Matrixyl (Palmitoyl Pentapeptide-4) Dosage Guide
Evidence-based topical protocols for one of the most clinically validated anti-aging peptides in cosmeceuticals — concentrations, application methods, collagen stimulation, stacking with GHK-Cu, Argireline, retinol, and vitamin C.
In This Guide
What Is Matrixyl?
Matrixyl (palmitoyl pentapeptide-4, also known as pal-KTTKS) is a lipopeptide consisting of the pentapeptide sequence KTTKS (Lys-Thr-Thr-Lys-Ser) linked to palmitic acid — a fatty acid chain that enables the peptide to penetrate the skin's lipid barrier. Developed by the French biotech company Sederma, Matrixyl is one of the most clinically validated anti-aging peptides in the cosmeceutical industry.
The KTTKS sequence is a fragment of the C-terminal propeptide of type I procollagen. When collagen is naturally broken down in the skin, small fragments called matrikines are released. These matrikine fragments act as biological signals, telling fibroblasts (the cells that produce collagen) to ramp up production of new extracellular matrix components. Matrixyl mimics this natural process — it tricks fibroblasts into behaving as though collagen breakdown has occurred, stimulating them to produce new collagen, fibronectin, and glycosaminoglycans (including hyaluronic acid) to “repair” the perceived damage.
Unlike many research peptides discussed on this site, Matrixyl is a cosmeceutical peptide designed exclusively for topical application. It is not injectable. Its primary use is in anti-aging skincare formulations — serums, creams, and eye treatments — where it stimulates collagen synthesis in the dermis to reduce wrinkle depth and improve skin firmness.
Use our Peptide Dosage Calculator for reconstitution math if working with raw peptide powder for custom topical formulations.
Key Characteristics:
- Matrikine signaling peptide — mimics collagen breakdown fragments (matrikines) to signal fibroblasts to produce new collagen, fibronectin, and glycosaminoglycans
- Lipopeptide structure (pal-KTTKS) — palmitic acid chain enables penetration through the skin’s lipid-rich stratum corneum; KTTKS is the active signaling sequence from type I procollagen
- Clinically validated anti-aging efficacy — double-blind studies demonstrating wrinkle depth reduction comparable to retinol without the irritation, redness, or photosensitivity
- Topical only — not injectable — designed and studied exclusively for topical application in skincare formulations; standard concentrations range from 2–8% in serums and creams
- Excellent safety and tolerability — non-irritating, non-sensitizing, no photosensitivity; suitable for sensitive skin, rosacea-prone skin, and the delicate eye area
- Multiple Matrixyl generations — original Matrixyl (pal-KTTKS), Matrixyl 3000 (pal-KTTKS + pal-GHK), and Matrixyl Synthe’6 (palmitoyl tripeptide-38) each offer progressively broader matrix stimulation
For a complete overview of its mechanism and research, see our full Matrixyl profile. New to peptides? Start with the Beginner's Guide to Peptides.
How Matrixyl Dosage Is Determined
Unlike injectable peptides dosed in micrograms, Matrixyl dosing is expressed as a percentage concentration in topical formulations. The effective concentration has been established through controlled clinical trials, in vitro fibroblast studies, and extensive commercial use across the cosmeceutical industry.
Landmark Clinical Research
The foundational clinical study for Matrixyl was a double-blind, placebo-controlled trial comparing pal-KTTKS at 100 ppm (0.01%) against vehicle control and retinol. The study demonstrated significant reduction in wrinkle depth and volume after 12 weeks of twice-daily application, with efficacy comparable to retinol but without the irritation, peeling, or photosensitivity associated with vitamin A derivatives. This study established that even very low concentrations of pal-KTTKS are biologically active.
In Vitro Fibroblast Studies
Cell culture studies have demonstrated that pal-KTTKS stimulates type I collagen synthesis, type III collagen synthesis, and fibronectin production in human dermal fibroblasts in a dose-dependent manner. The peptide activates fibroblasts at micromolar concentrations, and the palmitoyl chain significantly enhances cellular uptake compared to the unmodified KTTKS pentapeptide alone. These in vitro findings confirm the matrikine signaling mechanism and support the clinical dose ranges.
Commercial Formulation Standards
Based on clinical data, Sederma recommends Matrixyl at 2–8% concentration in finished cosmetic products (where the raw material itself contains the peptide in a carrier solution). Effective commercial serums typically contain 2–5% Matrixyl, with professional-grade formulations reaching 8–10%. The wide range reflects differences in product format (lightweight serums vs. rich creams), complementary ingredients, and target market positioning.
Penetration Enhancement
The palmitic acid chain conjugated to KTTKS is not merely a structural feature — it is the key to skin penetration. The unmodified KTTKS peptide alone has poor dermal penetration because the skin's outer layer (stratum corneum) is a lipid-rich barrier that repels water-soluble molecules. By attaching a C16 fatty acid chain, pal-KTTKS becomes lipophilic enough to pass through this barrier and reach the dermal fibroblasts where it exerts its signaling effect.
Standard Matrixyl Dosage Ranges
Matrixyl dosing is expressed as the percentage of the Matrixyl ingredient (which contains pal-KTTKS in a carrier solution) in the finished product. Application frequency and amount are also important variables that affect overall peptide delivery to the skin.
Concentration Ranges
| Level | Concentration | Application | Best For | Notes |
|---|---|---|---|---|
| Minimal Effective | 100 ppm (0.01%) | 2x daily | Clinical study threshold | Lowest concentration shown effective in controlled studies; most commercial products use higher levels |
| Standard Consumer | 2–5% | 2x daily | General anti-aging maintenance | Most common range in effective consumer serums; good balance of efficacy and cost |
| Professional Grade | 5–8% | 1–2x daily | Targeted wrinkle reduction | Higher-end serums and professional formulations; stronger collagen stimulation |
| Maximum | 8–10% | 1–2x daily | Intensive treatment protocols | Upper practical limit; diminishing returns above 8%; used in concentrated treatment products |
Application Protocol
- Frequency: Apply 2x daily (morning and evening) for optimal results
- Amount: A pea-sized amount of serum for the full face; half that for the eye area alone
- Layering order: Cleanser → toner (optional) → Matrixyl serum → treatment creams → moisturizer → sunscreen (AM only)
- Skin prep: Apply to clean, slightly damp skin for optimal absorption; the palmitoyl chain handles penetration through the lipid barrier
- Consistency: Daily use for a minimum of 8–12 weeks before assessing results; collagen remodeling is a gradual process
Matrixyl Variants Compared
Sederma has developed several generations of Matrixyl, each building on the original matrikine signaling concept with additional peptides or broader matrix targets. Understanding the differences helps you choose the right variant for your goals.
| Variant | Composition | Key Targets | Mechanism | Best For |
|---|---|---|---|---|
| Matrixyl (Original) | Palmitoyl pentapeptide-4 (pal-KTTKS) | Collagen I, III; fibronectin | Matrikine signaling (procollagen fragment mimic) | General anti-aging; wrinkle reduction |
| Matrixyl 3000 | pal-KTTKS + palmitoyl tripeptide-1 (pal-GHK) | Collagen I, III, IV; fibronectin; hyaluronic acid | Dual matrikine signaling: KTTKS (collagen fragment) + GHK (wound repair signal) | Enhanced anti-aging; deeper wrinkles |
| Matrixyl Synthe'6 | Palmitoyl tripeptide-38 | Collagen I, III, IV; fibronectin; hyaluronic acid; laminin-5 | Stimulates 6 major skin matrix components simultaneously | Comprehensive matrix repair; skin firmness |
Which Variant Should You Use?
- Matrixyl (original): Well-proven, widely available, cost-effective. Excellent starting point for anyone new to peptide skincare. Strong clinical data specifically for this formulation.
- Matrixyl 3000: The most popular variant in modern formulations. The addition of pal-GHK provides a second signaling pathway (GHK is a well-studied wound-repair and collagen-stimulating tripeptide). Generally preferred over the original when available, as it offers broader matrix stimulation at the same concentration.
- Matrixyl Synthe'6: The newest generation. Targets the broadest range of extracellular matrix components, including laminin-5 (important for the dermal-epidermal junction). Best for comprehensive skin matrix repair and for users who want the most advanced formulation available.
Formulation & Application
Most users will purchase pre-formulated Matrixyl serums or creams. However, for those creating custom formulations or compounding their own topical products, understanding the formulation basics is important. For raw peptide powder calculations, our dosage calculator can help with the math.
Pre-Formulated Product Selection Checklist:
- Concentration: Look for 2–5% Matrixyl (or Matrixyl 3000) listed in the product specifications
- Ingredient position: pal-KTTKS or palmitoyl pentapeptide-4 should appear in the upper third of the ingredient list
- pH: Optimal formulation pH is 5.0–6.0 for pal-KTTKS stability
- Packaging: Opaque, airless pump bottles preserve peptide stability better than open jars or clear bottles
- Base: Water-based serums allow better layering; cream-based products provide additional moisturization
Application Technique
| Step | Action | Why It Matters |
|---|---|---|
| 1. Cleanse | Wash face with a gentle cleanser; pat dry leaving skin slightly damp | Removes surface oils and debris that block peptide absorption |
| 2. Tone (optional) | Apply hydrating toner or essence | Balances skin pH and provides a hydrated base for serum absorption |
| 3. Apply Matrixyl | Dispense a pea-sized amount; press gently into skin (do not rub vigorously) | Gentle pressing enhances absorption; aggressive rubbing can displace product |
| 4. Wait 1–2 min | Allow serum to absorb before applying next layer | Prevents dilution and allows the palmitoyl chain to begin penetrating the lipid barrier |
| 5. Layer treatments | Apply any additional serums, then moisturizer | Thinnest to thickest layering ensures each product absorbs properly |
| 6. Sunscreen (AM) | Apply broad-spectrum SPF 30+ as the final step | UV protection is essential; UV degrades collagen faster than peptides can rebuild it |
Custom Formulation? Use Our Calculator
If you are compounding a custom topical formulation from raw peptide powder, use our calculator to determine reconstitution volumes and concentrations.
Matrixyl Dosage by Goal
While Matrixyl is primarily used for anti-aging, the specific protocol can be tailored depending on your primary skin concern. Concentration, application area, and complementary ingredients vary by goal.
Fine Lines & Wrinkle Prevention (Maintenance)
For users in their late 20s to 30s looking to prevent collagen loss and maintain skin firmness before significant wrinkles develop. This is a proactive anti-aging approach focused on stimulating ongoing collagen production to counteract the natural decline that begins in the mid-20s.
- Concentration: 2–3% Matrixyl or Matrixyl 3000
- Application: 2x daily (AM and PM), full face and neck
- Duration: Ongoing daily use as part of regular skincare routine
- Stack: + vitamin C serum (AM) for antioxidant protection + sunscreen for UV defense
Moderate Wrinkle Reduction (Active Treatment)
For visible fine lines and moderate wrinkles. Higher concentrations and more targeted application maximize collagen stimulation in areas of concern. This protocol targets the forehead, crow's feet, nasolabial folds, and neck lines.
- Concentration: 4–8% Matrixyl 3000 or Matrixyl Synthe'6
- Application: 2x daily, focused on wrinkle-prone areas (forehead, around eyes, nasolabial folds, neck)
- Duration: Minimum 12 weeks before assessing; continue ongoing
- Stack: + retinol 0.3–0.5% (PM) for dual-pathway collagen stimulation + Argireline for expression line relaxation
Eye Area Anti-Aging
The periorbital area has the thinnest skin on the face and shows aging earliest. Matrixyl is one of the best actives for this area because it does not cause the irritation, dryness, or peeling that retinol produces on delicate eye skin.
- Concentration: 2–5% Matrixyl 3000
- Application: 2x daily, gentle tapping around the orbital bone (avoid direct eye contact)
- Duration: Ongoing; results visible within 8–12 weeks
- Stack: + hyaluronic acid serum for hydration plumping + caffeine for puffiness and dark circle support
Neck & Décolletage Firming
The neck and chest area often shows aging as prominently as the face but is frequently neglected in skincare routines. These areas respond well to peptide treatments because the skin is relatively thin and accessible to topical actives.
- Concentration: 3–5% Matrixyl or Matrixyl 3000
- Application: 2x daily, extending application from jaw to upper chest
- Duration: Minimum 12–16 weeks; neck skin remodels more slowly than facial skin
- Stack: + GHK-Cu serum for comprehensive matrix remodeling + retinol (if tolerated) for enhanced collagen production
Post-Procedure Skin Recovery
After professional treatments (chemical peels, microneedling, laser resurfacing), Matrixyl can support the skin's natural repair process by stimulating collagen and matrix production during the recovery phase. It is gentle enough for compromised skin barriers.
- Concentration: 2–5% Matrixyl 3000
- Application: 2x daily, starting 24–48 hours post-procedure (or per practitioner guidance)
- Duration: 4–8 weeks during recovery period
- Stack: + hyaluronic acid for barrier repair hydration + GHK-Cu for wound healing and remodeling support (avoid retinol during active recovery)
Duration & Long-Term Use
Unlike injectable peptides that typically require cycling (on-periods and off-periods) to prevent receptor desensitization or hormonal disruption, Matrixyl is designed for continuous long-term topical use. There is no receptor desensitization concern because pal-KTTKS works as a matrikine signal, not a receptor agonist that could downregulate.
| Phase | Timeframe | What to Expect | Notes |
|---|---|---|---|
| Initial (Building) | Weeks 1–4 | Improved skin hydration and texture; collagen synthesis begins but is not yet visible | Be patient; do not expect wrinkle changes yet |
| Early Results | Weeks 4–8 | Subtle improvements in fine lines; skin firmness begins to improve; texture smoother | Many users notice changes around week 6–8 |
| Visible Results | Weeks 8–16 | Measurable wrinkle depth reduction; improved skin firmness and elasticity; visible smoothing | Clinical studies measured significant changes at 12 weeks |
| Ongoing Maintenance | 4+ months | Continued collagen support; maintenance of improvements; cumulative benefits | Designed for indefinite daily use; no cycling required |
When to Reassess Your Protocol
- At 12 weeks: Evaluate results. If improvements are minimal, consider increasing concentration, adding complementary actives (retinol, vitamin C, GHK-Cu), or switching to Matrixyl 3000 or Synthe'6 for broader matrix stimulation.
- Seasonally: You may want a lighter formulation in summer and a richer one in winter, but the peptide concentration should remain consistent year-round.
- After professional procedures: Adjust your routine post-treatment as guided by your dermatologist or aesthetician. Matrixyl can typically be resumed within 24–48 hours of most procedures.
- If skin sensitivity develops: While rare with Matrixyl, if you add new actives (retinol, AHAs) that cause irritation, simplify your routine and reintroduce products one at a time.
Matrixyl Stacking Protocols
Matrixyl stacks exceptionally well with other topical actives because its matrikine signaling mechanism does not overlap with the pathways used by retinoids, antioxidants, or neuromuscular peptides. Combining Matrixyl with complementary ingredients creates multi-pathway anti-aging routines that address wrinkles, firmness, texture, and protection simultaneously.
Matrixyl + GHK-Cu — The Collagen Powerhouse Stack
Combines Matrixyl's matrikine signaling with GHK-Cu's copper-mediated matrix remodeling for maximum collagen and elastin production. GHK-Cu stimulates collagen through a different mechanism (copper-dependent enzymatic pathways, TGF-β activation, and metalloproteinase regulation), making this a true dual-pathway collagen stack.
Matrixyl + Argireline — The Expression Line Stack
Combines collagen-building (Matrixyl) with neuromuscular relaxation (Argireline) for a comprehensive approach to dynamic wrinkles — the lines formed by repeated facial expressions (smiling, frowning, squinting). Matrixyl rebuilds the dermal collagen matrix that supports the skin, while Argireline reduces the muscle contractions that crease it.
| Compound | Concentration / Dose | When | Purpose |
|---|---|---|---|
| Matrixyl | 3–5% serum, 2x daily | AM and PM, full face | Collagen stimulation; dermal matrix support |
| Argireline | 5–10% serum, 2x daily | AM and PM, expression areas | SNARE complex inhibition; reduces muscle contraction intensity at expression lines |
Matrixyl + Retinol + Vitamin C — The Triple Threat Anti-Aging Stack
The most comprehensive topical anti-aging combination, targeting collagen through three independent pathways: Matrixyl (matrikine signaling), retinol (retinoic acid receptor activation), and vitamin C (cofactor for collagen hydroxylation + antioxidant protection). This stack also provides UV defense (vitamin C), cell turnover (retinol), and matrix rebuilding (Matrixyl).
| Compound | Concentration / Dose | When | Purpose |
|---|---|---|---|
| Matrixyl | 3–5% serum, 2x daily | AM and PM | Matrikine collagen stimulation; fibronectin production |
| Vitamin C (L-ascorbic acid) | 10–20% serum, 1x daily | AM (under sunscreen) | Collagen cofactor; antioxidant protection; photoprotection |
| Retinol | 0.3–1% cream, 1x daily | PM only | Cell turnover; retinoic acid receptor collagen stimulation; skin remodeling |
Matrixyl + Argireline + SNAP-8 — The Botox Alternative Stack
Maximizes the topical “botox-like” effect by combining collagen rebuilding (Matrixyl) with two neuromuscular peptides that reduce expression line depth through SNARE complex inhibition. Argireline (acetyl hexapeptide-3) and SNAP-8 (acetyl octapeptide-3) both target neurotransmitter release at the neuromuscular junction but through slightly different SNARE protein interactions.
| Compound | Concentration / Dose | When | Purpose |
|---|---|---|---|
| Matrixyl | 3–5% serum, 2x daily | AM and PM, full face | Collagen matrix rebuilding; structural skin support |
| Argireline | 5–10% serum, 2x daily | AM and PM, expression lines | SNAP-25 inhibition; reduces muscle contraction for dynamic wrinkles |
| SNAP-8 | 3–5% serum, 2x daily | AM and PM, expression lines | Broader SNARE complex modulation; complements Argireline mechanism |
Explore more combinations with our Peptide Stack Builder or browse the Top 10 Peptide Stacks guide.
Safety, Side Effects & Contraindications
Side Effects
Extremely rare and mild:
- Mild skin irritation — very rare; may occur in individuals with extremely reactive or compromised skin barriers; typically resolves by reducing application frequency
- Contact sensitization — exceedingly rare with pal-KTTKS; more likely caused by other ingredients in the formulation (preservatives, fragrances) rather than the peptide itself
- Breakouts — occasional reports, likely related to the vehicle/base of the product (comedogenic oils or silicones) rather than the Matrixyl peptide; switching to a lighter formulation typically resolves this
NOT associated with Matrixyl:
- No photosensitivity (unlike retinol — no increased sun sensitivity)
- No peeling, flaking, or purging phase (unlike retinol and AHAs)
- No systemic absorption or hormonal effects (acts locally in skin only)
- No skin thinning (unlike long-term corticosteroid use)
- No tolerance or desensitization with long-term use
- No drug interactions with topical application
Contraindications
- Known allergy to any ingredient in the formulation — discontinue immediately if rash, hives, or itching develops. Patch test on the inner forearm before first facial use if you have a history of cosmetic allergies.
- Active skin infections or open wounds — do not apply Matrixyl to infected skin, active cold sores, or open wounds. Wait until the skin has healed before applying cosmeceutical products.
- Immediately after aggressive procedures — wait 24–48 hours (or per practitioner guidance) after chemical peels, laser treatments, or microneedling before applying peptide serums.
Patch Testing
While Matrixyl rarely causes reactions, a simple patch test is good practice for any new skincare product:
- Apply a small amount to the inner forearm or behind the ear
- Wait 24–48 hours
- If no redness, itching, or irritation develops, proceed with facial use
- If any reaction occurs, the culprit may be another ingredient in the formulation (preservatives, fragrances) rather than the peptide itself — try a different Matrixyl product with a simpler ingredient list
Common Matrixyl Mistakes
Avoid these common errors to get the most out of your Matrixyl protocol:
Many budget serums contain trace amounts of Matrixyl for label appeal without providing an effective concentration. Clinical studies used at least 100 ppm (0.01%), and most effective consumer products contain 2–8%. Check ingredient lists — if pal-KTTKS or Matrixyl appears near the bottom of a long ingredient list, the concentration is likely too low to produce meaningful collagen stimulation.
Collagen synthesis is a biological process that takes weeks to months. New collagen fibers must be produced by fibroblasts, assembled into a structural network, and deposited in the dermis before visible wrinkle improvement occurs. Give Matrixyl at least 8–12 weeks of consistent twice-daily use before assessing results. Most users who report “it didn’t work” quit after 2–3 weeks — far too early.
Water-based Matrixyl serums should be applied to clean skin before heavier products. Applying a water-based peptide serum over thick creams, oils, or silicone-based primers creates a barrier that prevents penetration. The correct layering order is: cleanser → toner → Matrixyl serum → treatment creams → moisturizer → sunscreen (AM).
Matrixyl (pal-KTTKS), Matrixyl 3000 (pal-KTTKS + pal-GHK), and Matrixyl Synthe’6 (palmitoyl tripeptide-38) are different products with different compositions. Matrixyl 3000 is not simply a “stronger version” of Matrixyl — it adds a second peptide for complementary matrix stimulation. Synthe’6 is an entirely different peptide. Know which variant your product contains when comparing results or following protocols.
Peptide stability decreases with heat and light exposure. Store Matrixyl serums in a cool, dark place (room temperature is fine; refrigeration extends shelf life). Do not leave serums in direct sunlight, near a window, or in a hot bathroom. Degraded peptides lose their signaling activity and become ineffective. If a serum changes color, develops an unusual smell, or becomes cloudy, discard it.
Matrixyl is most stable and effective at a near-neutral to slightly acidic pH (around 5–6). Applying it simultaneously with strong acids like glycolic acid (pH 2–3) or L-ascorbic acid at very low pH can denature the peptide and reduce its efficacy. If you use chemical exfoliants or low-pH vitamin C, apply them at a separate time of day or wait 20–30 minutes between applications to allow skin pH to normalize.
Topical Matrixyl stimulates collagen production in the superficial dermis and is effective for fine lines, skin texture, and mild-to-moderate wrinkles. It does not replace injectable treatments (dermal fillers, botulinum toxin) for deep wrinkles, volume loss, or muscle-driven expression lines. Matrixyl is best positioned as a daily maintenance treatment that complements professional procedures, not as a substitute for them.
UV radiation degrades collagen faster than any topical can rebuild it. Using Matrixyl to stimulate new collagen production while exposing unprotected skin to UV damage is counterproductive. Always apply broad-spectrum SPF 30+ as the final step in your morning routine. Without sun protection, even the most effective peptide regimen will produce disappointing results.
Frequently Asked Questions
Key Takeaways
- Matrixyl (pal-KTTKS) is a matrikine signaling peptide — it mimics collagen breakdown fragments to stimulate fibroblasts to produce new collagen, fibronectin, and glycosaminoglycans
- Topical only — not injectable — designed and validated for topical application in skincare serums and creams at 2–8% concentration
- Clinically validated: double-blind studies demonstrate wrinkle reduction comparable to retinol without irritation, peeling, or photosensitivity
- Apply 2x daily: morning and evening on clean skin, before heavier creams and sunscreen. A pea-sized amount for the full face.
- Allow 8–12 weeks minimum: collagen remodeling is gradual; visible wrinkle improvements require consistent long-term use
- No cycling required: unlike injectable peptides, Matrixyl is designed for continuous daily use without desensitization concerns
- Best collagen stack: Matrixyl + GHK-Cu for dual-pathway collagen stimulation (matrikine + copper-mediated)
- Best expression line stack: Matrixyl + Argireline for collagen rebuilding + neuromuscular relaxation
- Excellent for retinol-intolerant skin: the leading non-irritating alternative for collagen stimulation in sensitive, rosacea-prone, or reactive skin
- Always use sunscreen: UV radiation degrades collagen faster than any topical can rebuild it — SPF 30+ daily is essential alongside any anti-aging peptide protocol
This article is for educational and informational purposes only. Matrixyl (palmitoyl pentapeptide-4 / pal-KTTKS) is a cosmeceutical ingredient used in topical skincare products. It is not a drug and is not FDA-approved to diagnose, treat, cure, or prevent any disease. Results may vary. Consult a dermatologist for personalized skincare advice, especially if you have pre-existing skin conditions. See our Medical Disclaimer.
References
- Robinson LR, et al. “Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin.” Int J Cosmet Sci. 2005;27(3):155-160.
- Katayama K, et al. “A pentapeptide from type I procollagen promotes extracellular matrix production.” J Biol Chem.1993;268(14):9941-9944.
- Lintner K, Peschard O. “Biologically active peptides: from a laboratory bench curiosity to a functional skin care product.” Int J Cosmet Sci.2000;22(3):207-218.
- Gorouhi F, Maibach HI. “Role of topical peptides in preventing or treating aged skin.” Int J Cosmet Sci. 2009;31(5):327-345.
- Lupo MP, Cole AL. “Cosmeceutical peptides.” Dermatol Ther. 2007;20(5):343-349.
- Schagen SK. “Topical peptide treatments with effective anti-aging results.” Cosmetics. 2017;4(2):16.
- Pickart L, et al. “GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration.” Biomed Res Int. 2015;2015:648108.
- Blanes-Mira C, et al. “A synthetic hexapeptide (Argireline) with antiwrinkle activity.” Int J Cosmet Sci. 2002;24(5):303-310.
- Fields K, et al. “Bioactive peptides: signaling the future.” J Cosmet Dermatol. 2009;8(1):8-13.
Next Steps
Continue your research with these resources.
GHK-Cu Dosage Guide
Learn dosing protocols for GHK-Cu — the copper peptide that pairs with Matrixyl for maximum collagen stimulation.
Read GuideDosage Calculator
Calculate reconstitution volumes and concentrations for custom topical peptide formulations.
Open CalculatorPeptide Directory
Browse all peptides with research summaries and dosing data.
View Directory